0001209191-23-023864.txt : 20230407
0001209191-23-023864.hdr.sgml : 20230407
20230407204127
ACCESSION NUMBER: 0001209191-23-023864
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230405
FILED AS OF DATE: 20230407
DATE AS OF CHANGE: 20230407
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kihara James
CENTRAL INDEX KEY: 0001816160
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50768
FILM NUMBER: 23809534
MAIL ADDRESS:
STREET 1: C/O ACADIA PHARMACEUTICALS INC.
STREET 2: 12830 EL CAMINO REAL, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 061376651
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-558-2871
MAIL ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-04-05
0
0001070494
ACADIA PHARMACEUTICALS INC
ACAD
0001816160
Kihara James
C/O ACADIA PHARMACEUTICALS, INC.
12830 EL CAMINO REAL, SUITE 400
SAN DIEGO
CA
92130
0
1
0
0
Principal Accounting Officer
0
Common Stock
2023-04-05
4
M
0
2009
A
4932
D
Common Stock
2023-04-06
4
S
0
701
18.16
D
4231
D
Restricted Stock Units
2023-04-05
4
M
0
2009
0.00
D
Common Stock
2009
6030
D
Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.16 to $18.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The restricted stock units vest in four equal annual installments beginning April 5, 2023.
/s/ Austin D. Kim, Attorney-in-Fact
2023-04-07